City Research Online

Article

Aitken, L. M. ORCID: 0000-0001-5722-9090, Emerson, L. M. ORCID: 0000-0002-4250-5758, Kydonaki, K. , Blackwood, B., Creagh-Brown, B., Lone, N. I., McKenzie, C. A., Reade, M. C., Weir, C. J., Wise, M. P. & Walsh, T. S.view all authors (2024). Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B trial): protocol for a mixed-methods process evaluation of a randomised controlled trial. BMJ Open, 14(4), article number e081637. doi: 10.1136/bmjopen-2023-081637

Walsh, T. S., Aitken, L. M. ORCID: 0000-0001-5722-9090, McKenzie, C. A. , Boyd, J., Macdonald, A., Giddings, A., Hope, D., Norrie, J., Weir, C., Parker, R. A., Lone, N. I., Emerson, L. M. ORCID: 0000-0002-4250-5758, Kydonaki, K., Creagh-Brown, B., Morris, S., McAuley, D. F., Dark, P., Wise, M. P., Gordon, A. C., Perkins, G., Reade, M., Blackwood, B., MacLullich, A., Glen, R. & Page, V. J.view all authors (2023). Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK. BMJ Open, 13(12), article number e078645. doi: 10.1136/bmjopen-2023-078645

Aitken, L. M. ORCID: 0000-0001-5722-9090, Kydonaki, K., Blackwood, B. , Trahair, L. G., Purssell, E. ORCID: 0000-0003-3748-0864, Sekhon, M. & Walsh, T. S.view all authors (2021). Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis. Thorax, 76(11), pp. 1089-1098. doi: 10.1136/thoraxjnl-2020-216098

Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N. H., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O’Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A. M., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J.view all authors (2020). More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumonia. Annals of Translational Medicine, 8(13), article number 840. doi: 10.21037/atm-20-3701

Hellyer, T. P., McAuley, D. F., Walsh, T. S. , Anderson, N., Conway Morris, A., Singh, S., Dark, P., Roy, A. I., Perkins, G. D., McMullan, R., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Wright, S. E., Kefala, K., O'Kane, C. M., Baudouin, S. V., Paterson, R. L., Rostron, A. J., Agus, A., Bannard-Smith, J., Robin, N. M., Welters, I. D., Bassford, C., Yates, B., Spencer, C., Laha, S. K., Hulme, J., Bonner, S., Linnett, V., Sonksen, J., Van Den Broeck, T., Boschman, G., Keenan, D. W. J., Scott, J., Allen, A. J., Phair, G., Parker, J., Bowett, S. A. & Simpson, A. J.view all authors (2019). Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. The Lancet Respiratory Medicine, 8(2), pp. 182-191. doi: 10.1016/s2213-2600(19)30367-4

Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J.view all authors (2016). Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial. Trials, 17(1), article number 318. doi: 10.1186/s13063-016-1442-x

Hellyer, T. P., Anderson, N. H., Parker, J. , Dark, P., Van Den Broeck, T., Singh, S., McMullan, R., Agus, A. M., Emerson, L. M. ORCID: 0000-0002-4250-5758, Blackwood, B., Gossain, S., Walsh, T. S., Perkins, G. D., Morris, A. C., McAuley, D. F. & Simpson, A. J.view all authors (2016). Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’. Trials, 17(1), article number 465. doi: 10.1186/s13063-016-1594-8